Arcturus Therapeutics (ARCT) Prices 3.26M Share Common Offering at $53/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
After-Hours Movers 07/28: (BGFV) (KODK) (AMD) Higher; (KODK) (RRD) (STX) Lower (more...)
July 28, 2020 6:04 PM EDTToday's After-Hours Movers
Big 5 Sporting Goods (NASDAQ: BGFV) 47% HIGHER; reported Q2 EPS of $0.52, versus $0.00 reported last year. Revenue for the quarter came in at $227.94 million, versus $240.97 million reported last year.
Eastman Kodak Company (NYSE: KODK) 36% HIGHER; adds to 200%+ intra-day gains as Trump mentioned the deal to produce drug ingredients
Community Health Systems (NYSE: CYH) 16.5% HIGHER; reported Q2 EPS of $0.85, $1.47 better than the analyst estimate of ($0.62). Revenue for... More
Arcturus Therapeutics (ARCT) Announces Proposed Public Offering of Common Stock
July 28, 2020 4:15 PM EDTArcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares... More
Arcturus Therapeutics (ARCT) PT Raised to $78 at H.C. Wainwright
July 27, 2020 6:36 AM EDTH.C. Wainwright analyst Ed Arce raised the price target on Arcturus Therapeutics (NASDAQ: ARCT) to $78.00 (from $62.00) while maintaining a Buy rating.... More
